Moonia (Desogestrel)

Desogestrel, the active ingredient in Moonia, is a progestin presented as an oral tablet for oral use. It is employed to prevent pregnancy by inhibiting ovulation and altering cervical mucus in women of reproductive age.

GNH USA supplies Moonia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desogestrel is a progestin used primarily in hormonal contraception to prevent pregnancy.

- Prevention of pregnancy: Provides reliable hormonal contraception to inhibit ovulation. - Oral contraceptive use: Formulated as a progestin‑only oral pill for family planning. - Menstrual cycle regulation: Helps maintain regular menstrual cycles in women using hormonal contraception.

Desogestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset that usually resolves with continued use. - Headache: occasional tension‑type headaches. - Breast tenderness: mild discomfort or swelling of the breasts. - Weight gain: modest increase in body weight. - Irregular bleeding: spotting or changes in menstrual flow.

Serious or Rare Side Effects: - Deep vein thrombosis: formation of blood clots in deep veins. - Pulmonary embolism: clot migration to the lungs. - Liver tumor: rare hepatic neoplasm. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Desogestrel requires careful consideration of several safety factors before use.

- Contraindicated in pregnancy: Category X drug must not be taken during pregnancy. - Smoking in women over 35: increased risk of cardiovascular events. - History of thromboembolism: avoid use due to clotting risk. - Liver disease: use with caution; monitor hepatic function. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Desogestrel can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants: may reduce contraceptive efficacy. - Rifampicin: decreases plasma levels of desogestrel. - St. John’s wort: may lower hormonal protection.

Moderate Interactions (Monitor Closely): - Antifungal azoles: can increase desogestrel concentrations. - Macrolide antibiotics: may elevate hormone levels, requiring monitoring.